NF2 and malignant mesothelioma: While genetic alterations in Hippo signaling are rare in human cancer, several pathway components, particularly NF2, are frequently inactivated by somatic mutations in malignant mesothelioma, leading to common YAP/TAZ activation in this rare type of cancer [67].